Nabriva therapeutics plc (NBRV)
Balance Sheet / Quarterly
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Dec'15
Assets
Current assets:
Cash and cash equivalents

26,938

86,019

78,101

58,666

91,042

102,003

100,331

75,253

89,441

86,769

112,158

20,089

27,166

32,778

36,446

Restricted cash

444

392

228

-

-

-

-

-

-

-

-

-

-

-

-

Short-term investments

175

175

175

15,253

225

225

326

225

110

110

531

33,084

41,061

51,106

74,994

Accounts receivable, net and other receivables

3,467

2,744

6,540

-

-

3,871

-

-

-

-

-

-

-

-

-

Other receivables

-

-

-

4,766

7,238

-

7,362

6,820

6,436

5,402

3,673

8,699

7,448

5,561

4,195

Contract asset

-

-

-

-

1,000

1,500

1,500

1,500

1,500

-

-

-

-

-

-

Inventory

4,224

682

162

-

-

-

-

-

-

-

-

-

-

-

-

Prepaid expenses

2,925

1,158

1,202

1,403

973

1,154

1,163

1,150

1,016

1,558

1,510

1,353

903

1,176

610

Total current assets

38,173

91,170

86,408

80,088

100,478

108,753

110,682

84,948

98,503

93,839

117,872

63,225

76,578

90,621

116,245

Property, plant and equipment, net

2,340

2,474

2,655

2,761

2,972

1,139

1,226

1,285

1,376

1,327

1,405

1,437

490

519

417

Intangible assets, net

111

91

343

86

99

98

109

127

155

172

199

211

224

270

3

Long-term receivables

378

378

716

710

438

428

428

428

428

425

420

408

424

420

430

Deferred tax assets

-

-

-

-

-

-

-

-

-

-

-

2,093

1,232

1,410

616

Total assets

41,002

94,113

90,122

83,645

103,987

110,418

112,445

86,788

100,462

95,763

119,896

67,374

78,948

93,240

117,711

Liabilities and equity
Current liabilities:
Accounts payable

2,033

4,673

3,221

2,914

7,562

3,304

4,765

2,928

3,807

5,136

5,319

8,323

4,337

2,551

2,928

Accrued expense and other current liabilities

9,929

11,966

11,663

11,202

10,533

14,502

10,300

8,364

7,577

8,124

11,014

8,432

11,553

13,326

5,823

Income taxes payable

-

-

-

-

-

-

-

-

-

-

-

-

-

-

170

Total current liabilities

11,962

16,639

14,884

14,116

18,095

17,806

15,065

11,292

11,384

13,260

16,333

16,755

15,890

15,877

8,921

Non-current liabilities
Long-term debt

7,374

34,502

34,241

24,306

23,945

23,718

710

592

411

232

227

218

203

-

-

Other non-current liabilities

1,752

1,698

1,782

1,818

1,840

264

244

236

225

203

198

146

134

107

84

Total non-current liabilities

9,126

36,200

36,023

26,124

25,785

23,982

954

828

636

435

425

364

337

107

-

Total liabilities

21,088

52,839

50,907

40,240

43,880

41,788

16,019

12,120

12,020

13,695

16,758

17,119

16,227

15,984

9,005

Commitments and contingencies (Note 12)

-

-

-

-

-

-

0

0

0

-

0

0

0

0

0

Investment from silent partnership

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

Total mezzanine equity

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

Stockholders’ Equity:
Ordinary shares, nominal value $0.01, 1,000,000,000 ordinary shares authorized at March 31, 2020; 94,545,116 and 95,109,047 issued and outstanding at December 31, 2019 and March 31, 2020, respectively

951

945

780

729

713

670

665

410

402

367

-

-

2,946

2,939

2,407

Ordinary shares, nominal value $0.01, 1,000,000,000 ordinary shares authorized at December 31, 2017; 36,707,685 issued and outstanding at December 31, 2017

-

-

-

-

-

-

-

-

-

-

367

268

-

-

-

Preferred shares, par value $0.01, 100,000,000 shares authorized at March 31, 2020; None issued and outstanding

-

-

-

-

-

-

0

0

0

-

0

0

-

0

-

Treasury shares - at cost; 0 shares at December 31, 2016 and 0 shares at March 31, 2017, respectively

-

-

-

-

-

-

-

-

-

-

-

-

0

-

25

Additional paid in capital

518,937

517,044

492,105

478,551

473,562

461,911

458,887

384,557

380,553

360,872

359,680

283,960

279,848

279,149

273,921

Accumulated other comprehensive income

27

27

27

27

27

27

27

27

27

27

27

-16

-7

10

3,829

Accumulated deficit

-500,001

-476,742

-453,697

-435,902

-414,195

-393,978

-363,153

-310,326

-292,540

-279,198

-256,936

-234,667

-220,066

-204,842

-171,426

Total stockholders’ equity

19,914

41,274

39,215

43,405

60,107

68,630

96,426

74,668

88,442

82,068

103,138

49,545

62,721

77,256

108,706

Non-controlling interest

-

-

-

-

-

-

-

-

-

-

-

710

-

-

-

Total stockholders' equity

-

-

-

-

-

-

-

-

-

-

-

50,255

-

-

-

Total liabilities and stockholders’ equity

41,002

94,113

90,122

83,645

103,987

110,418

112,445

86,788

100,462

95,763

119,896

67,374

78,948

93,240

117,711